Germline News and Research

RSS

Targeted therapy may be of great benefit in early stage breast cancer

Targeted therapy in early stages of breast cancer can pave the way for a notable higher success rate, shows a study from the University of Bergen, Norway.

20 Apr 2021

New approach to scale up genome editing in tiny worms

Understanding the effects of specific mutations in gene regulatory regions - the sections of DNA and RNA that turn genes on and off - is important to unraveling how the genome works, as well as normal development and disease.

13 Apr 2021

Have scientists found SARS-CoV-2's Achilles' heel?

Have scientists uncovered the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Achille's heel? New preclinical research from Cell neutralizing antibodies targeting the N-terminal domain of the coronavirus could be a potential target for antibodies to bind and effectively neutralize SARS-CoV-2.

29 Mar 2021

Rare genetic variant may explain severe COVID-19 in young healthy male patients

A recent study describes the association of rare alleles in a specific gene with severe COVID-19 in young male patients.

29 Mar 2021

Underrepresentation in genomic databases may affect therapy selection for minority patients

Low representation of minority groups in public genomic databases may affect therapy selection for Black patients with cancer, according to new Mayo Clinic research published in npj Precision Oncology.

19 Mar 2021

Study investigates how genetic variants contribute to increased risk of lung cancer

Lung cancer is the leading cause of cancer death in the U.S. for both men and women. While risk for this disease can be influenced by environmental and lifestyle factors like smoking, studies estimate that 18% of lung cancer cases are due to inherited genetic variants.

18 Mar 2021

Researchers develop rapid method for identifying antibody-resistant SARS-CoV-2 mutants

Researchers in the United States have described a novel rapid method for identifying antibody-resistant mutants in SARS-CoV-2.

17 Mar 2021

Research demonstrates multivalent nanobodies overcome SARS-CoV-2 variant mutations

In a recent bioRxiv* preprint paper, researchers isolated anti-RBD nanobodies from llamas and “nanomice” (they engineered to produce VHHs cloned from alpacas, dromedaries and camels).

10 Mar 2021

Somatic gene mutations in brain cells could contribute to schizophrenia pathology

Schizophrenia is a neurodevelopmental disorder that disrupts brain activity producing hallucinations, delusions, and other cognitive disturbances. Researchers have long searched for genetic influences in the disease, but genetic mutations have been identified in only a small fraction--fewer than a quarter--of sequenced patients.

9 Mar 2021

Could small synthetic antigen proteins be diagnostic tools for SARS-CoV-2?

Researchers have developed small proteins from sequences in SARS-CoV-2's RBD that bind to ACE2. These were as effective in binding to neutralizing antibodies as larger RBD proteins.

2 Mar 2021

Retroviruses invading the koala germline contribute to high cancer rates

Koalas are facing multiple environmental and health issues which threaten their survival. Along with habitat loss - accelerated by last year’s devastating bush fires – domestic dog attacks and road accidents, they suffer from deadly chlamydial infections and extremely high frequency of cancer.

26 Feb 2021

Scientists describe genetic mechanisms behind mating process of ciliates

Conjugation (or mating) of ciliates is a unique phenomenon among living beings. They have sex not for reproduction or pleasure — they seek to increase genetic variation.

20 Feb 2021

Study outlines the reasons to test pediatric cancer patients for inherited genes

Because cancers in children are rare, many details about their biology remain unknown. In the field of cancer genetics, there's a limited understanding of how inherited genetic changes may contribute to the formation and growth of tumors.

16 Feb 2021

Clonally expanded plasma cell lineages in SARS-CoV-2 produce specific neutralizing antibodies

A new preprint research paper posted to the bioRxiv server provides a greater understanding of the aspect of humoral immunity against the virus – the plasma cells that pour out a flood of specific antibodies targeting various epitopes on the pathogen.

16 Feb 2021

Germline News and Research

Targeted therapy may be of great benefit in early stage breast cancer

New approach to scale up genome editing in tiny worms

Have scientists found SARS-CoV-2's Achilles' heel?

Rare genetic variant may explain severe COVID-19 in young healthy male patients

Underrepresentation in genomic databases may affect therapy selection for minority patients

Study investigates how genetic variants contribute to increased risk of lung cancer

Researchers develop rapid method for identifying antibody-resistant SARS-CoV-2 mutants

Research demonstrates multivalent nanobodies overcome SARS-CoV-2 variant mutations

Somatic gene mutations in brain cells could contribute to schizophrenia pathology

Could small synthetic antigen proteins be diagnostic tools for SARS-CoV-2?

Retroviruses invading the koala germline contribute to high cancer rates

Scientists describe genetic mechanisms behind mating process of ciliates

Study outlines the reasons to test pediatric cancer patients for inherited genes

Clonally expanded plasma cell lineages in SARS-CoV-2 produce specific neutralizing antibodies

Naïve B cells can neutralize SARS-CoV-2 via RBD recognition

Scientists characterize genomic profile of 84 pediatric therapy-related myeloid neoplasms

Inherited genetic variation may affect the response to cancer immunotherapy

Monoclonal antibodies against SARS-CoV-2 spike's N-terminal prove highly protective in vivo

Phase 1 clinical trial of novel HIV vaccine approach shows promising results

Toward patient-derived models to help personalize cancer care

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News